

A Turkish company issues new shares to a related party and dilutes a foreign investor’s ownership. Learn how capital increases, pre-emption rights, shareholder resolutions, bad faith and cancellation claims can be challenged in Turkey.
A foreign investor may enter a Turkish company with a significant ownership percentage only to discover later that the majority shareholder has arranged a capital increase and caused new shares to be issued to itself, an affiliate, family member or another related party. The result can be dramatic: the foreign investor’s percentage falls, voting influence weakens and control of the company may effectively shift without the investor selling a single share. Under Turkish company law, dilution resulting from a capital increase is not automatically unlawful. However, where a capital increase, restriction of subscription rights or allocation of new shares is structured primarily to weaken a particular shareholder rather than satisfy a genuine corporate financing need, the transaction may become open to serious legal challenge.
Yes. Turkish companies can increase their capital and issue new shares if the applicable statutory, articles-of-association and corporate-governance requirements are satisfied.
The mere fact that an existing foreign shareholder’s percentage decreases does not by itself establish illegality.
The central questions are why the capital increase occurred, how the decision was adopted, whether existing shareholders were given their legally protected participation rights and whether the transaction improperly favored related parties.
Assume a foreign investor owns 30% of a Turkish company. The company subsequently increases its capital substantially. If the foreign investor cannot or is not permitted to subscribe for new shares while another shareholder acquires them, the foreign investor’s percentage may fall significantly.
Although the investor still owns the same number of shares, its relative ownership, voting power and economic influence have been diluted.
No.
A company may genuinely require new capital to finance expansion, satisfy working-capital requirements, repay debt or undertake investments.
If the capital increase has a legitimate corporate purpose and applicable shareholder rights are respected, dilution can be a lawful consequence.
The legal problem becomes more significant when evidence indicates that the transaction was designed primarily to weaken a minority or foreign investor.
A new share issuance deserves particular scrutiny where the recipient is connected with the controlling shareholder.
Examples may include a parent company, subsidiary, sister company, family member, business associate or another entity controlled directly or indirectly by the majority shareholder.
The relationship does not automatically invalidate the transaction, but it can be highly relevant when evaluating its purpose and fairness.
The foreign investor should immediately obtain the corporate documents relating to the transaction.
These may include the shareholders’ meeting or board resolution, meeting invitation, agenda, attendance records, minutes, capital-increase documentation, amendments to the articles of association and commercial registry records.
The procedural history can reveal important defects.
A shareholder should determine whether the meeting was convened according to applicable requirements and the company’s articles of association.
Improper notice may become important where the investor was effectively prevented from attending or exercising shareholder rights.
Review whether the capital increase and any related restriction of shareholder rights were properly addressed through the required corporate procedure.
A shareholder should not discover after the meeting that a fundamentally important ownership transaction was implemented without the necessary procedural transparency.
Existing shareholders generally have important rights concerning participation in newly issued shares according to their existing ownership interests, subject to the applicable company structure and legal framework.
These rights can protect shareholders from unexpected dilution.
A foreign investor should therefore determine whether it was legally entitled to subscribe for new shares and, if so, whether that opportunity was genuinely provided.
This can be one of the central issues in a dilution dispute.
If the company restricted or removed the foreign shareholder’s right while allowing a related party to acquire the new shares, the legal justification for that restriction should be examined carefully.
The controlling shareholder should not assume that possession of sufficient votes allows shareholder protections to be disregarded.
The applicable statutory requirements, corporate interest, equal-treatment principles and limitations on majority power may become relevant.
Examine why the company allegedly required additional capital.
Relevant evidence can include financial statements, cash-flow information, bank debts, investment plans, board presentations and communications with shareholders.
If the company had no identifiable financial need and the capital increase appeared immediately after a shareholder dispute, the timing may become significant evidence.
Consider whether the capital increase occurred shortly after the foreign investor:
challenged management decisions; requested company records; questioned related-party transactions; refused to sell its shares; demanded dividends; sought removal of a director; or commenced negotiations concerning a shareholder dispute.
A suspicious sequence of events can be relevant to establishing the commercial context of the transaction.
The amount of new capital should also be examined.
A capital increase far exceeding the company’s demonstrated financing needs may raise questions where its practical effect is to reduce a minority investor’s ownership drastically.
The amount alone is not decisive, but it can become important when combined with other evidence.
Corporate registry searches and ownership records may reveal that the apparent new investor is economically connected with the existing controller.
Foreign investors should examine beneficial ownership and control relationships rather than relying only on the name appearing in formal company records.
Another important issue is the economic terms on which new shares were issued.
If a valuable company issues shares to a related party on unusually favorable terms, the transaction may cause not only voting dilution but also economic transfer of value away from existing shareholders.
A financial valuation may therefore be necessary.
A company may own valuable real estate, intellectual property, customer relationships, licenses or profitable contracts that are not fully reflected in nominal capital.
Where new shares are issued cheaply to a related party, independent valuation can become central to the dispute.
Turkish corporate law contains principles designed to protect shareholders against unjustified discriminatory treatment.
If similarly situated shareholders are treated differently without legitimate corporate justification, the affected investor may have grounds to challenge the decision.
A controlling shareholder generally possesses significant decision-making authority, but corporate voting power is not unlimited.
Using corporate mechanisms solely to damage another shareholder, obtain an improper advantage or transfer value to related parties can raise questions concerning abuse of majority power and good faith.
The company’s articles may contain important protections concerning capital increases, privileged shares, voting rights, board nominations, transfer restrictions or enhanced voting requirements.
Foreign investors sometimes focus exclusively on statutory law and overlook contractual corporate protections already embedded in the articles.
If the parties signed a shareholders’ agreement, examine provisions concerning:
capital increases; reserved matters; investor consent; anti-dilution rights; pre-emption rights; funding obligations; board approval; related-party transactions; deadlock; share valuation; exit rights; and dispute resolution.
A transaction may generate both corporate-law and contractual claims.
Investment agreements sometimes contain protections specifically designed to prevent or economically compensate for dilution.
The precise wording should be examined carefully because contractual anti-dilution protection can differ significantly from statutory subscription rights.
Potentially.
Depending on the company type, resolution, procedural history and grounds involved, an affected shareholder may be able to pursue cancellation, invalidity or another appropriate corporate-law remedy.
The correct action should be determined from the exact resolution rather than assuming every defective transaction requires the same lawsuit.
Corporate-resolution challenges can be subject to short statutory periods.
A foreign investor who discovers a suspicious capital increase should therefore obtain the relevant corporate documents and legal advice immediately rather than spending months negotiating informally.
Document the date on which the investor received meeting notices, minutes, registry information, emails or other evidence concerning the capital increase.
The chronology can become important both procedurally and evidentially.
Registration should not automatically be understood as eliminating every possible legal challenge.
The legal consequences depend on the defect, transaction and remedy pursued.
Foreign investors should therefore avoid assuming that nothing can be done merely because the capital increase has already been registered.
Where implementation of a disputed transaction may cause difficult-to-reverse consequences, interim judicial protection may become important.
Depending on the circumstances and legal requirements, the investor may evaluate measures aimed at preserving the existing position while the underlying dispute is litigated.
Once newly issued shares begin carrying voting rights, they may affect subsequent shareholder resolutions, management appointments and other corporate decisions.
Delay can therefore allow one disputed transaction to influence several later corporate actions.
If allegedly improperly issued shares were subsequently used to control another shareholders’ meeting, each later decision should be examined separately.
The investor should map the sequence of corporate actions rather than focusing only on the first capital increase.
The investor should seek relevant records showing existing shareholders, share transfers, new subscriptions and changes following the capital increase.
Corporate records can help establish who ultimately benefited.
Communications can be particularly important where management previously discussed reducing the foreign investor’s ownership or forcing the investor to sell.
Emails, messages, meeting notes and written proposals should be preserved lawfully.
Determine whether the related party actually paid the required subscription amount and trace the source of funds where legally relevant.
A nominal capital contribution that was never genuinely funded may raise additional questions.
In complex shareholder disputes, money may appear to enter the company but ultimately originate from the company itself or another related entity.
Bank records and accounting entries may therefore require forensic review.
The capital increase should not necessarily be examined in isolation.
Review whether the company transferred assets, made loans, paid unusual management fees or entered into other transactions benefiting the controlling group around the same period.
A corporate finance expert can assess the company’s value before and after the transaction, the economic value transferred through the new issuance and the resulting loss suffered by the diluted investor.
This can be important where monetary claims accompany corporate-law remedies.
Potentially, depending on the unlawful conduct, persons responsible, causation and proven loss.
The availability of damages should be evaluated separately from cancellation of the corporate decision.
If directors or managers participated in an unlawful transaction that harmed the company or shareholders, their responsibilities may need to be examined under the applicable corporate framework.
The fact that a majority shareholder wanted the transaction does not automatically resolve management’s separate duties.
Where the controlling shareholder orchestrated the transaction for its own benefit, claims involving abuse of shareholder rights or other applicable principles may need to be considered in addition to challenges against the corporate resolution itself.
Not every aggressive capital increase constitutes a criminal offense.
Criminal-law analysis should be based on specific conduct and evidence, such as falsified documents, fraudulent transactions or other independently unlawful acts.
Corporate disputes should not automatically be converted into criminal accusations.
If dilution is followed by replacement of directors or restriction of information access, obtaining documents may become more difficult.
Preserve lawfully available financial statements, corporate resolutions, contracts and communications as early as possible.
Shareholder information and inspection rights can help uncover the rationale and financial background of the transaction.
The exact rights and enforcement mechanisms depend on the company type and circumstances.
The shareholders’ agreement may contain Turkish court jurisdiction, arbitration or another dispute-resolution mechanism.
Corporate resolution challenges and contractual claims may not necessarily follow the same procedural route, so jurisdiction should be analyzed carefully.
Even where a shareholders’ agreement contains an international arbitration clause, certain corporate-law questions involving a Turkish company may require separate analysis concerning arbitrability, corporate effects and available court remedies.
The investor should map each claim individually.
A serious dilution dispute can involve several parallel questions: validity of the capital increase, restriction of subscription rights, contractual breach, interim protection, management liability, valuation and damages.
These claims should be coordinated rather than filed independently without a broader strategy.
A foreign investor discovering suspicious dilution should immediately obtain the capital-increase resolution and meeting documents, review the articles of association and shareholders’ agreement, identify how subscription rights were treated, investigate the relationship between the controlling shareholder and new subscriber, determine the commercial justification for the capital increase, preserve communications, examine the subscription payment, obtain financial valuation where necessary, identify challenge deadlines and evaluate urgent interim judicial protection.
Yes. Dilution can lawfully result from a valid capital increase. The issue is whether applicable corporate procedures and shareholder protections were respected.
Potentially, but the transaction may require careful scrutiny concerning corporate purpose, shareholder rights, equal treatment and economic terms.
Restrictions may be possible under applicable corporate rules, but the legal requirements and justification should be examined carefully.
Not necessarily. The investor should establish the relevant procedural or substantive grounds for challenging the decision.
Potentially. Registration does not automatically eliminate every possible remedy. The nature of the defect and applicable procedural rules must be examined.
Potentially, where the legal requirements for interim protection are satisfied and implementation threatens difficult-to-reverse consequences.
That relationship can be highly relevant when assessing the purpose and economic substance of the transaction.
Potentially. Monetary claims depend on the unlawful conduct, responsible persons, causation and proof of loss.
Potentially, where their conduct in approving or implementing the transaction breaches applicable corporate duties and causes legally compensable loss.
Obtain the complete corporate record immediately and protect all applicable challenge periods. The strongest cases generally combine procedural evidence with financial evidence showing how the capital increase was structured, who benefited, whether there was a genuine financing need and how the foreign investor’s shareholder rights were affected.
Shareholder dilution disputes can involve capital increases, pre-emption rights, related-party share issuances, abuse of majority power, shareholders’ agreements, corporate resolutions, injunctions, director liability, company valuation and damages claims.
Fırat Fesih Kaya Law Office assists foreign investors and international shareholders facing corporate-control and shareholder disputes involving Turkish companies. Lawyer Fırat Fesih Kaya provides legal assistance in reviewing disputed capital increases, challenging corporate resolutions, seeking interim protection, investigating related-party transactions, enforcing shareholder agreements and pursuing appropriate compensation claims.
Phone: +90 312 434 22 22
Mobile: +90 532 769 22 22
Email: info@firatfesihkaya.av.tr
Address: Mevlana Boulevard No:221, Yıldırım Tower, Office No:148, 06520 Balgat, Çankaya, Ankara, Turkey